CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.07M | 110.20M | 118.75M | 132.42M | 131.74M |
| Total Depreciation and Amortization | 72.04M | 71.40M | 70.67M | 70.46M | 70.15M |
| Total Amortization of Deferred Charges | 6.95M | 7.12M | 7.14M | 7.10M | 7.46M |
| Total Other Non-Cash Items | 43.95M | 15.93M | 10.32M | -3.29M | -19.16M |
| Change in Net Operating Assets | -19.31M | -39.44M | -27.50M | -39.72M | -10.16M |
| Cash from Operations | 167.69M | 165.21M | 179.38M | 166.97M | 180.03M |
| Capital Expenditure | -18.74M | -16.97M | -14.83M | -13.08M | -13.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 850.00K | 850.00K | 850.00K | -- | 0.00 |
| Cash from Investing | -17.89M | -16.12M | -13.98M | -13.08M | -13.90M |
| Total Debt Issued | 683.67M | 659.67M | 663.00M | 751.00M | 781.00M |
| Total Debt Repaid | -774.25M | -747.25M | -765.59M | -823.00M | -857.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -24.73M | -24.71M | -24.68M | -24.65M | -24.62M |
| Other Financing Activities | -34.20M | -32.53M | -35.12M | -54.35M | -58.07M |
| Cash from Financing | -149.52M | -144.83M | -162.38M | -151.00M | -158.70M |
| Foreign Exchange rate Adjustments | 175.00K | 800.00K | -1.39M | -2.72M | 535.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 462.00K | 5.07M | 1.63M | 163.00K | 7.97M |